C.E. Credits

The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here

The presentational method for this activity will be Lecture with an opportunity for real-time question and answer periods for the live activity, and on demand access of the presentation for the enduring material activity. Both the internet live course and the internet activity enduring material are geared towards Medical Professionals, Research Scientists, Principal Investigators, Lab Directors, and Clinicians. This activity will encompass the following desirable physician attributes:  Patient Care & Procedural Skills, Medical Knowledge, Professionalism, and Interpersonal & Communication Skills.

Desired Outcomes

At the end of the activity, participants should be able to:

1.    Demonstrate a detailed appreciation of and appropriately use the range of tools and technologies that make up Molecular Diagnostics, including Regulations in Molecular Diagnostics, Clinical Laboratory Testing, Precision medicine in Oncology, Liquid Biopsies: Applications in Molecular Diagnostics, Genomic Health and more
2.    Cite the current and established medical science principles and the application of these principles to patient care, including information in personal and family histories that indicate a need for molecular diagnostic testing


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME®) through the joint providership of CME Consultants and LabRoots. CME Consultants is accredited by the ACCME® to provide continuing medical education for physicians.

CME Consultants designates this internet live activity for a maximum of 5.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Consultants designates this internet live activity enduring material for a maximum of 5.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material release date: 4/13/18

Enduring Material Termination date: 7/13/18

In accordance with the Americans with Disability Act (ADA), please contact LabRoots at ce@labroots.com should you require special assistance.


APR 11 - 12 2018

Molecular Diagnostics 2018

Our  3rd Annual Molecular Diagnostics Virtual Conference is now available On Demand! The Molecular Diagnostics Event is the premiere venue for scientists, technologists, and professionals to discuss and present the newest advances in molecular diagnostics testing. 

Learn from keynote speaker and renown expert Dr. Eunice Lee, Branch Chief of Molecular Pathology and Cytology Branch with the FDA, and other experts like Dr. Steven Lee of University of California, Berkeley; Dr. Judd Moul from Duke University Medical Center; and Dr. Jason Kralj from NIST. Enjoy the complementary conference from your desk with no need for travel, and explore the virtual exhibit hall to learn about the latest technologies and techniques for your lab.

Topics in the 2018 event included:

  • Regulatory Changes
  • Point of Care
  • Diagnostic Testing
  • Emerging Trends:
    • Data sharing and some of the emerging trends
    • Forensic molecular biology
    • Microfluidic devices for handling cells and biomolecules

Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (CE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation, you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.

Produced on a new, more robust platform, you can watch, learn and connect during this conference on mobile devices easier than ever before. Equipped with a leaderboard and scavengerhunt, you can now move around the entire event earning points for a chance to win one of LabRoots most popular shirts

Use #LRmoldx to follow the conversation!


Speakers
  • Branch Chief, Molecular Pathology & Cytology Branch, Division of Molecular Genetics & Pathology, Office of In Vitro Diagnostics & Radiological Health, FDA
  • James H Semans MD Professor of Surgery, Division of Urologic Surgery, Director, Duke Prostate Center, Duke Cancer Institute, Duke University Medical Center
  • Personalized Medicine Integration Manager, Inova Center for Personalized Health
  • Product Marketing Manager, Target Enrichment, New England Biolabs
  • Vice President and Chief Medical Officer, Genomic and Clinical Pathology Services, PathGroup
  • Professor, School for the Future of Innovation in Society and Consortium for Science, Policy & Outcomes, Arizona State University
  • Principal at Roger D. Klein, MD JD Consulting and Klein & Klein Co., L.P.A. Faculty Fellow at the Arizona State University Sandra Day O'Connor College of Law's Center for Law, Science &
  • Associate Professor, University of Nebraska Medical Center
  • Product Director, QIAGEN
  • Leader of the Metagenomic Pathogen Detection Program, National Institute of Standards and Technology
  • Senior Scientist, Biomedical Genomics, QIAGEN
  • Chief Scientific Officer, 3D Signatures Inc.
  • Vice President, Business Development, Scienion
  • Professor, Department of Pathology and Laboratory Medicine, Women & Infants Hospital/Alpert Medical School at Brown University
  • Marketing Manager, Scienion
  • Scientific and General Director, Cellenion
  • Associate Professor of Medicine, Department of Molecular Genetics and Microbiology, Duke University School of Medicine
  • Professor and Chief Clinical Chemistry and Toxicology, Department of Pathology and Laboratory Medicine, University of Louisville School of Medicine
  • Assistant Professor, Molecular Biology & Biochemistry/Pediatrics, University of California, Irvine
  • System Director, Clinical and Molecular Biology at Geisinger Diagnostic Medicine Institute

Show Resources
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer reviewed. Submission is free.

SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster

All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Questions? Email Posters@LabRoots.com

LabRoots Policy

Agenda
  • APR 11, 2018 06:00 AM PDT
    Speaker: Robert Cook-Deegan, MD
  • APR 11, 2018 07:30 AM PDT
    Speaker: Eunice Lee, PhD
  • APR 11, 2018 09:00 AM PDT
    Speaker: Donna Wolk, MHA, PhD, D(ABMM)
    Sponsored By: Diasorin, Inc.
  • APR 11, 2018 09:00 AM PDT
    Speaker: Pranil Chandra, DO
  • APR 11, 2018 10:30 AM PDT
    Barbara McIntosh
    Vice President, Business Development, Scienion
    Alba Simon
    Marketing Manager, Scienion
    Guilhem Tourniaire
    Scientific and General Director, Cellenion
  • APR 11, 2018 10:30 AM PDT
    Speaker: Roger Klein MD, JD, FCAP
  • APR 11, 2018 12:00 PM PDT
    Speaker: Glenn Palomaki, PhD
  • APR 11, 2018 01:30 PM PDT
    Speaker: Donald Klepser, PhD
  • APR 12, 2018 06:00 AM PDT
    Speaker: Roland Valdes Jr., PhD, DABCC, FACC
  • APR 12, 2018 07:30 AM PDT
    Speaker: Judd W Moul, MD, FACS
  • APR 12, 2018 09:00 AM PDT
    Speaker: Amjaad Al-Hussain, MHSA
  • APR 12, 2018 09:00 AM PDT
    Speaker: Katrine Whiteson, PhD
  • APR 12, 2018 09:00 AM PDT
    Speaker: Francesco Lescai, PhD, EDBT
  • APR 12, 2018 10:30 AM PDT
    Speaker: Kevin Little, PhD
  • APR 12, 2018 12:00 PM PDT
    Speaker: Ephraim Tsalik, MD, PhD
  • APR 12, 2018 12:00 PM PDT
    Speaker: Jason Kralj, PhD
  • APR 12, 2018 01:30 PM PDT
    Speaker: Andrew Barry
  • Emerging Trends
  • APR 11, 2018 06:00 AM PDT
    Speaker: Robert Cook-Deegan, MD
  • APR 11, 2018 09:00 AM PDT
    Speaker: Pranil Chandra, DO
  • APR 11, 2018 10:30 AM PDT
    Barbara McIntosh
    Vice President, Business Development, Scienion
    Alba Simon
    Marketing Manager, Scienion
    Guilhem Tourniaire
    Scientific and General Director, Cellenion
  • APR 12, 2018 06:00 AM PDT
    Speaker: Roland Valdes Jr., PhD, DABCC, FACC
  • APR 12, 2018 09:00 AM PDT
    Speaker: Katrine Whiteson, PhD
  • APR 12, 2018 10:30 AM PDT
    Speaker: Kevin Little, PhD
  • APR 12, 2018 12:00 PM PDT
    Speaker: Jason Kralj, PhD
  • Regulatory Changes
  • APR 11, 2018 07:30 AM PDT
    Speaker: Eunice Lee, PhD
  • APR 11, 2018 10:30 AM PDT
    Speaker: Roger Klein MD, JD, FCAP
  • Diagnostic Testing
  • APR 11, 2018 09:00 AM PDT
    Speaker: Donna Wolk, MHA, PhD, D(ABMM)
    Sponsored By: Diasorin, Inc.
  • APR 12, 2018 09:00 AM PDT
    Speaker: Amjaad Al-Hussain, MHSA
  • Biomarkers and NGS Integration in Diagnostics
  • APR 11, 2018 12:00 PM PDT
    Speaker: Glenn Palomaki, PhD
  • APR 12, 2018 07:30 AM PDT
    Speaker: Judd W Moul, MD, FACS
  • APR 12, 2018 09:00 AM PDT
    Speaker: Francesco Lescai, PhD, EDBT
  • APR 12, 2018 12:00 PM PDT
    Speaker: Ephraim Tsalik, MD, PhD
  • APR 12, 2018 01:30 PM PDT
    Speaker: Andrew Barry
  • Point of Care
  • APR 11, 2018 01:30 PM PDT
    Speaker: Donald Klepser, PhD
Speakers

  • Eunice Lee, PhD
    Branch Chief, Molecular Pathology & Cytology Branch, Division of Molecular Genetics & Pathology, Office of In Vitro Diagnostics & Radiological Health, FDA
    Biography
      Eunice Lee is currently Chief of the Molecular Pathology and Cytology Branch (MPCB) in the Office of In Vitro Diagnostics and Radiological Health in the Center for Devices and Radiological Health at the FDA. MPCB is responsible for reviewing regulatory submissions for a variety of in vitro diagnostic devices with oncology indications, including molecular and genomic assays, whole slide imaging systems, cytology collection devices, and companion diagnostics. Eunice graduated magna cum laude with an A.B. in biology and physics from Bryn Mawr College and a Ph.D. in biology from MIT. She completed fellowships at NIH and Stanford University and, prior to joining FDA, she worked at the National Cancer Institute.
    • Judd W Moul, MD, FACS
      James H Semans MD Professor of Surgery, Division of Urologic Surgery, Director, Duke Prostate Center, Duke Cancer Institute, Duke University Medical Center
      Biography
        Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of the Health Sciences (USUHS) in Bethesda, Maryland and an attending Urologic Oncologist at the Walter Reed Army Medical Center (WRAMC) in Washington, DC. In addition, he was Director of the Center for Prostate Disease Research (CPDR); a Congress-mandated research program of the Department of Defense based at USUHS and WRAMC. In 2004, he completed a 26-year U.S. Army career, retiring as a full Colonel in the Medical Corps, and became Chief of the Division of Urologic Surgery at Duke. Serving as Chief from 2004 to 2011, he brought innovation and growth to the program. Most notably, he started the Duke Prostate Center, expanded the urology residency training program through a novel collaboration with the Department of Defense and was able to maintain Duke Urology as a top 10 program in the nation throughout his tenure. Dr Moul completed his Urologic Oncology Fellowship at Duke University and graduated Summa Cum Laude from Pennsylvania State University. He earned his medical degree from Jefferson Medical College, where he was elected to Phi Beta Kappa and Alpha Omega Alpha. Dr Moul currently serves on the editorial boards of Prostate Cancer, Prostate Cancer and Prostatic Diseases, BJU International, American Journal of Mens Health, Brazilian Journal of Urology, World Journal of Urology, and Oncology REALTIME. He has published over 500 medical and scientific manuscripts and book chapters and has lectured at national and international meetings. He has appeared on ABC, NBC, CNN, PBS, and other media as a prostate cancer authority. Honors and awards received have included the American Medical Associations Young Physicians Section Community Service Award for his national involvement in prostate cancer patient support groups, the Sir Henry Welcome Research Medal and Prize from the Association of Military Surgeons of the United States, the prestigious Gold Cystoscope Award by the American Urological Association, the Baron Dominique Jean Larrey Military Surgeon Award for Excellence, the Order of Military Medical Merit from the Surgeon General at the US Army, and the Castle Connolly National Physician of the Year award.
      • Amjaad Al-Hussain, MHSA
        Personalized Medicine Integration Manager, Inova Center for Personalized Health
        Biography
          Amjaad Al-Hussain is the Personalized Medicine Integration Manager at Inova. In her role, Amjaad helps lead product development of genomic services and test integration at the Inova Center for Personalized Health. Amjaad has played a critical role in developing and growing MediMap® - Inova's pharmacogenomic testing program and the institution's first, trademarked, commercial product line. Since starting her career at Inova in 2010, Amjaad has been on the leading edge of the precision medicine movement. For her, being an advocate for genomic health is integral to achieving the mission of helping people and communities live longer, healthier lives. Amjaad holds a Master's degree in Health Systems Administration from Georgetown University. She is certified in Lean Six Sigma, received training from the Institute of Healthcare Improvement and was honored with the Excellence in Health Administration Award from the College of Health and Human Services at George Mason University.
        • Andrew Barry
          Product Marketing Manager, Target Enrichment, New England Biolabs
          Biography
            Andrew Barry is the Product Marketing Manager for Target Enrichment at New England Biolabs. He has a B.S. in Biology from Stonehill College, and Master of Science in Biomedical Engineering from Tufts University. Prior to joining NEB Andrew spent the first 10 years of his career at the Broad Institute of MIT and Harvard where he developed high-throughput processes for genomic applications. Following his time at the Broad, he joined Caliper Life Sciences (later acquired by PerkinElmer) where he held various positions in product management, strategic marketing, and R&D. Andrew joined New England Biolabs in 2016.
          • Pranil Chandra, DO
            Vice President and Chief Medical Officer, Genomic and Clinical Pathology Services, PathGroup
            Biography
              Dr. Chandra, is currently the Chief Medical Officer of Genomic and Clinical Pathology Services at PathGroup. Dr. Chandra holds board certifications in anatomic and clinical pathology, hematopathology and molecular genetic pathology. He completed his AP/CP training and fellowships in hematopathology, oncologic pathology and molecular pathology at NYU Langone Medical Center and the University of Texas-MD Anderson Cancer Center. While at MD Anderson, he served as Chief Fellow and received numerous awards for his research on translocation t(9;11) associated acute myeloid leukemia. Dr. Chandra joined PathGroup in 2011 as Associate Medical Director of Molecular Pathology and became Director in March of 2013. He has presented numerous abstracts and platform presentations at various pathology meetings, published articles in peer-reviewed journals and composed a book chapter on cutaneous T-cell lymphomas. Dr. Chandra is a member of the American Society of Clinical Pathology, Association of Molecular Pathology where he also serves on the Economic Affairs Committee and Clinical Practice Committee. Dr. Chandra also serves on the Personalized Healthcare Committee through the College of American Pathologists. Dr. Chandra is a medical consultant in molecular pathology and personalized medicine and is considered a national thought leader in Precision Oncology and Cancer Genomics.
            • Robert Cook-Deegan, MD
              Professor, School for the Future of Innovation in Society and Consortium for Science, Policy & Outcomes, Arizona State University
              Biography
                Robert Cook-Deegan is a professor, School for the Future of Innovation in Society, and Consortium for Science, Policy & Outcomes at Arizona State University. He founded and directed Duke's Center for Genome Ethics, Law & Policy 2002- 2012, and Duke-in-Washington through June 2016. Before Duke: National Academies of Science, Engineering and Medicine 1991-2002; National Center for Human Genome Research (NIH) 1989-1990; and congressional Office of Technology Assessment 1982-1988. MD, University of Colorado,1979; and BA in chemistry (magna cum laude), Harvard, 1975. Author of The Gene Wars: Science, Politics, and the Human Genome and over 250 other publications.
              • Roger Klein MD, JD, FCAP
                Principal at Roger D. Klein, MD JD Consulting and Klein & Klein Co., L.P.A. Faculty Fellow at the Arizona State University Sandra Day O'Connor College of Law's Center for Law, Science &
                Biography
                  Roger D. Klein, MD JD is an Expert with the Federalist Society Regulatory Transparency Project's FDA & Health Working Group, a former HHS Advisor to FDA, CMS and CDC, and a leading authority on public policies related to the implementation of precision medicine. A physician and an attorney, Dr. Klein was previously Medical Director of Molecular Oncology at Cleveland Clinic, and is presently a Faculty Fellow at the Arizona State University Sandra Day O'Connor College of Law's Center for Law, Science & Innovation. He has served in leadership roles in many cancer-related professional society committees, including current Chair of the Association for Molecular Pathology's (AMP's) Solid Tumors Division. He also serves on the American Society of Clinical Oncology's Government Relations Committee, and has been a member of the American Medical Association's CPT Molecular Pathology Advisory Group since its inception. Notably, Dr. Klein was an Expert and key spokesperson for AMP in its landmark lawsuit in which the U.S. Supreme Court invalidated patents on "the breast cancer genes." He is a frequent guest on national radio and television programs and a regular opinion contributor to The Hill, Real Clear Health, Investor's Business Daily, the Daily Caller, and other periodicals. Dr. Klein completed post-graduate medical training at Yale Medical School and obtained his J.D. from Yale Law School.
                • Donald Klepser, PhD
                  Associate Professor, University of Nebraska Medical Center
                  Biography
                    Donald Klepser is associate professor and vice chair of pharmacy practice at the University of Nebraska Medical Center, College of Pharmacy. He has a Ph.D. in Pharmaceutical Socioeconomics from the University of Iowa, an MBA from the University of Minnesota's Carlson School of Management, and a Bachelor's degree in Communications from the University of Michigan. He has studied the use of POC testing in community pharmacies for the past 11 years and is currently the primary investigator on grants to develop community pharmacy practice models for managing diseases such as HIV, HCV, influenza, and group A Streptococcus. He is also the primary investigator on grants to better understand how state and local health departments perceive the role of pharmacists conducting POC tests. As President of POC Consultants, Inc., Dr. Klepser has served as a consultant to both retail pharmacy chains and diagnostic testing companies.
                  • Yi Kong, Ph.D.
                    Product Director, QIAGEN
                    Biography
                      Yi is currently a Product Director at QIAGEN, responsible for content and application development of Cancer Molecular Research and Diagnostics. She led efforts to develop and commercialize the GeneReader NGS System. She has years of experience working in the diagnostic and pharmaceutical industries, in various development, product management, marketing and strategic planning roles. She started her career as a biomedical scientist, having published many peer-reviewed articles and a diagnostics patent.
                    • Jason Kralj, PhD
                      Leader of the Metagenomic Pathogen Detection Program, National Institute of Standards and Technology
                      Biography
                        Dr. Jason Kralj has worked at NIST since 2006, and is a member of the Complex Microbial Systems Group led by Scott Jackson. Currently, he is developing a pathogen DNA reference material to address some of the analytical challenges facing next generation sequencing-based metagenomics.
                      • Francesco Lescai, PhD, EDBT
                        Senior Scientist, Biomedical Genomics, QIAGEN
                        Biography
                          Dr. Francesco Lescai graduated in Medical Biotechnology at the University of Bologna and was a awarded a Ph.D. in experimental pathology, with studies in genetics of human ageing and Alzheimer Disease. He then pioneered the analysis of human exomes at University College London, first at UCL Genomics and then at the Centre for Translational Genomics, Institute of Child Health and Great Ormond Street Hospital. Francesco then took on the position of Associate Professor of Human Genomics and Bioinformatics at the Department of Biomedicine of Aarhus University, where his main research focus was the use of genome sequencing in the area of precision medicine, and in particular the genetic causes of psychiatric disorders such as schizophrenia and autism. He joined QIAGEN in November 2017 as a Senior Scientist for Biomedical Genomics, in the Global Product Management team for CLC Workbenches. Francesco has been a member of the Executive Board of the European Federation of Biotechnology, is in the Editorial Board of several journals and has been in different Expert Groups at the European Commission. He also coordinates a Horizon2020 project on responsible industrial innovation.
                        • Kevin Little, PhD
                          Chief Scientific Officer, 3D Signatures Inc.
                          Biography
                            Kevin has a passion for leading life sciences ventures through the creation of collaborative business ecosystems. Prior to his position at 3DS, Kevin worked as an independent consultant, offering strategic advisory services to help facilitate new life sciences collaborations for public and private sector clients. Kevin previously led the PERFORM Centre, a $36 Million health research and community services complex, as the Founding Chief Administrative Officer. There, he established and oversaw all operations across nine business units. Before returning to Canada to lead the start-up of the PERFORM Centre, Kevin spent several years leading the New Zealand government's economic development efforts to build strategic investment relationships across the biotechnology industry sector. Kevin holds a Bachelor of Science degree in Biology from the University of Victoria, and earned his Ph.D. in Experimental Medicine from McGill University, specializing in DNA repair and functional human genomics. During his Ph.D. studies, he was part of a biotech start-up developing clinical assays to map the functional organization of the human genome. Kevin went on to complete a postdoctoral fellowship in translational neuroscience and clinical gene therapy at the University of Auckland in New Zealand. Kevin is a Certified Strategic Alliance Professional.
                          • Barbara McIntosh
                            Vice President, Business Development, Scienion
                            Biography
                              Barbara McIntosh, Vice President for Business Development at SCIENION US since 2016. For over 20 years, Barbara has been working in the diagnostic and life science marketplace on specific point of care applications like continuous glucose monitoring (CGM), lateral flow, multiplex arrays, and other microfluidic devices. She has been both an invited speaker at global conferences as well as a published author. She holds a BS degree in Biology and a MS in Management. bmcintosh@scienion.com
                            • Glenn Palomaki, PhD
                              Professor, Department of Pathology and Laboratory Medicine, Women & Infants Hospital/Alpert Medical School at Brown University
                              Biography
                                Glenn E. Palomaki, PhD is the Associate Director of the Division of Medical Screening and Special Testing at Women & Infants Hospital of Rhode Island and a Professor in the Department of Pathology and Laboratory Medicine at the Alpert Medical School of Brown University. His main research interests are the statistical and methodological evaluations of screening and diagnostic tests. He has conducted multiple external validation studies demonstrating the screening or diagnostic performance of tests for genetic disorders as well as chronic diseases. He has led structured evidence reviews funded by the Centers for Disease Control and Prevention and provided statistical analyses for several other agencies. Dr. Palomaki has served on the Quality Assurance Committee of the American College of Medical Genetics where he helped author multiple laboratory standards and guidelines. Currently, he is a member of the Molecular and Biochemical Genetics Resource Committee of the College of American Pathologists and is involved in developing external quality assessment for next generation sequencing of cell free DNA in maternal circulation to identify common fetal aneuploidies. Since 2006, Dr. Palomaki has authored or co-authored 107 peer-reviewed articles and made 38 national and 22 international invited presentations. During that same time period, he has been (is) PI or Co-PI on three large industry-sponsored but independent clinical trials of diagnostic testing for fetal aneuploidy using cell free DNA in maternal circulation.
                              • Alba Simon
                                Marketing Manager, Scienion
                                Biography
                                  Originally from Spain, Alba holds a Master's Degree in Chemical Engineering from Strasbourg University and has been employed at SCIENION for two years now. She has been working closely with key accounts on the Mediterranean area, including diagnostic companies, medical centres and hospitals and research institutes in Spain, France, Italy and Portugal to introduce SCIENION dispensing technology and new cellenONE technology. Since recently, she is heading the Marketing Department. a.simon@scienion.com
                                • Guilhem Tourniaire
                                  Scientific and General Director, Cellenion
                                  Biography
                                    Guilhem studied Chemistry at the IUT of Montpellier, after an industrial placement at Unilever in Liverpool, he decided to further his study in the United Kingdom. There he undertook a Masters in Applied Chemistry from Kingston University and then received a PhD in high throughput Chemical Biology under the supervision of Professor Mark Bradley at the University of Edinburgh. After graduating he worked for several start-up companies. At Smart Holograms, he worked on the development of biosensors for glucose monitoring. At Altrika, he was project manager and developed biomaterials for stem cell culture and bacterial enrichment. In 2013, he decided to return to France and started working as sales manager and business developer for a German company called SCIENION AG. As part of this position, he established a business plan to investigate novel markets and applications related to precision cell dispensing. This latest assignment led to the creation of Cellenion in 2016, and his appointment as Scientific and Managing director. Cellenion is based in Lyon and specializes in the fields of bioprinting and single-cell isolation.
                                  • Ephraim Tsalik, MD, PhD
                                    Associate Professor of Medicine, Department of Molecular Genetics and Microbiology, Duke University School of Medicine
                                    Biography
                                      Ephraim Tsalik is an Associate Professor in the Department of Medicine and the Department of Molecular Genetics & Microbiology. He also holds an appointment in the Emergency Department Service at the Durham VA Health Care System. He earned his M.D. and Ph.D. from Columbia University followed by residency and fellowship training at Duke University. He also obtained a Masters in Health Services with a focus on Clinical Research. Through the Duke Center for Applied Genomics & Precision Medicine, Dr. Tsalik leads multiple translational research programs focused on understanding the dynamic between host and pathogen so as to discover and develop host-response markers that can diagnose and predict health and disease. This new and evolving approach to diagnosing illness has the potential to significantly impact individual as well as public health considering the rise of antibiotic resistance.
                                    • Roland Valdes Jr., PhD, DABCC, FACC
                                      Professor and Chief Clinical Chemistry and Toxicology, Department of Pathology and Laboratory Medicine, University of Louisville School of Medicine
                                      Biography
                                        Dr. Valdes is a Tenured Professor of Pathology and Laboratory Medicine and of Biochemistry and Molecular Biology at the University of Louisville's School of Medicine. He has held the appointment as Distinguished University Scholar and as Senior Vice-Chairman for the Department of Pathology. He presently serves as Chief of Clinical Chemistry and Toxicology for the University Hospital and as Director of the Clinical Chemistry Postdoctoral Fellowship Program. Dr. Valdes received his Ph.D. in Molecular Biophysics from the University of Virginia where he also completed postdoctoral training in Biochemistry and in Clinical Chemistry and Toxicology. Prior to his move to Louisville in 1989, Dr. Valdes was on the faculty at Washington University School of Medicine in St. Louis. He is a Diplomat of the American Board of Clinical Chemistry and a Fellow of the National Academy of Clinical Biochemistry. Dr. Valdes is nationally and internationally recognized as a leader in advancing the profession of clinical chemistry and personalized medicine through his contributions in promoting clinical chemistry as a discipline via the scholarships of clinical service, research, and teaching. Dr. Valdes has served on numerous federal/national committees such as CLIA and NIH Study Sections, and has served as President of several key professional organizations including the Clinical Ligand Assay Society (CLAS), the National Academy of Clinical Biochemistry (NACB), the Commission for Accreditation in Clinical Chemistry (ComACC), and, most recently, the Association of Clinical Scientists (ACS). Dr. Valdes has also served on the Board of Directors of the American Association for Clinical Chemistry (AACC) and as a Director on the American Board of Clinical Chemistry (ABCC). He has received several distinguished scientist and recognition awards from professional organizations such as the AACC, NACB, CLAS, and ACS and has authored more than 260 publications. Dr. Valdes holds several patents and is a pioneer in establishing the application of personalized and precision medicine via laboratory diagnostics by founding the first CLIA-accredited laboratory (PGXL Laboratories) focused on providing pharmacogenetic services. He continues working on developing novel laboratory services to enable the practice of precision/personalized medicine using advanced techniques in clinical chemistry.
                                      • Katrine Whiteson, PhD
                                        Assistant Professor, Molecular Biology & Biochemistry/Pediatrics, University of California, Irvine
                                        Biography
                                          Dr. Katrine Whiteson is interested in understanding how individual and persistent human-associated microbial and viral communities affect health. Infection with a bacterial pathogen, vaccination, immune development and even taking a Tylenol does not occur in a vacuum. Humans evolved in the presence of the dynamic microbial and viral communities that constantly inhabit our bodies, encoding the majority of unique metabolic genes. She studied Biochemistry at UC Berkeley (BA, 2000) and University of Chicago (PhD, 2007). During her PhD, Dr. Whiteson focused on the active site chemistry and DNA binding specificity of a site-specific recombinase from the class of proteins that enable the spread of antibiotic resistance genes. After working as a lecturer at UC Irvine for a year in 2007-2008, she moved to Geneva, Switzerland, and joined the Genomic Research Lab at the University of Geneva Hospitals with Dr. Jacques Schrenzel and Dr. Patrice Francois. This was an exciting era, just at the start of the Human Microbiome Project, for asking basic unanswered questions about the microbes and viruses inhabiting various niches of the human body. Dr. Whiteson focused on the oral microbial communities of healthy Europeans, and malnourished kids in Niger who develop a devastating facial gangrene known as noma. In 2011 she moved to Prof. Forest Rohwer's lab at San Diego State, where she undertook breath and sputum metabolite analysis to better understand the activity of CF patient microbial communities from Dr. Doug Conrad's Adult CF clinic at UCSD. Combining information about the genetic potential of a microbial community through DNA sequencing with the activity of the community by metabolite profiling is a powerful approach that Dr. Whiteson hopes to employ in future projects as she begins her own lab at University of California Irvine. More information can be found here: http://faculty.sites.uci.edu/whitesonlab/
                                        • Donna Wolk, MHA, PhD, D(ABMM)
                                          System Director, Clinical and Molecular Biology at Geisinger Diagnostic Medicine Institute
                                          Biography
                                            Dr. Donna Wolk is the System Director for Clinical and Molecular Microbiology at Geisinger Health System, an integrated delivery system in Pennsylvania. As a Diplomate of the American Board of Medical Microbiology (ABMM), Dr. Wolk's professional practice extends to the national and international level, supporting initiatives in clinical and molecular microbiology and laboratory leadership. Active in the American Society of Microbiology, among others, she is most well known for her strategic thinking and predications about new technology and its impact to patient care, as well as her work as one of seven founding members of CDC/ASM collaboration for Evidence Based Laboratory Medicine Best Practices. Dr. Wolk was selected as a Clinical Research Scholar at the University of Arizona and in 2012, she received the 1885 Distinguished Scholar Award, which acknowledges outstanding faculty whose research, scholarship, and creative contributions exemplify innovation, service, and success in their respective disciplines. She is the 2016 award laureate, selected by the American Society for Microbiology to receive the BD Award for Clinical Research in Microbiology.
                                          Sponsored By

                                          For information on becoming a sponsor or exhibitor, please click here.


                                          Committee

                                          To download the Program Committee brochure here.


                                          • Bryan Cobb, PhD, FACMG

                                            Dr. Cobb is the acting Director for Clinical Molecular Diagnostics at Roche Diagnostics Corporation where he serves in a scientific advisory role supporting the laboratory scientific community. He obtained his Ph.D. in Medical Genetics at the University of Alabama at Birmingham ...

                                            See more See less
                                          • Shawn Baker, PhD

                                            Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench ...

                                            See more See less
                                          • Martin Latterich, PhD

                                            The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...

                                            See more See less
                                          • Judd Moul, MD, FACS

                                            Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...

                                            See more See less
                                          • Emily Hollister, PhD

                                            Dr. Hollister is a microbial ecologist and bioinformaticist. She is interested in quantifying and characterizing microbial communities from a wide variety of environments, including the human body. Utilizing high throughput, next-generation DNA and RNA sequence approaches, her ...

                                            See more See less
                                          Help

                                          General LabRoots Questions

                                          For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                          Contact us

                                          Virtual Events and Webinars

                                          Supported Configurations

                                          • Operating System Internet Explorer Firefox Chrome Safari
                                            Vista IE8+ FF10+ Chrome15+
                                            Windows 7 IE8+ FF10+ Chrome15+
                                            Windows 8 IE10 FF10+ Chrome15+
                                            Mac OS X   FF10+ Chrome15+ Safari5.1+
                                          • Cookie settings: session cookies enabled
                                          • Browser configuration must have JavaScript enabled
                                          • Adobe Flash player 10.2 or later

                                          To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                          Internet Connection

                                          • A minimum of 100Kbps is recommended for audio-only events
                                          • A minimum of 300Kbps is recommended for speaker on-video events

                                          Computer Equipment

                                          • Screen Resolution: Minimum 1024x768
                                          • Video Card: 65,000 colors minimum
                                          • Sound card and speakers (or headphones) for hearing webcast in full format
                                          • Audio Card: 16-bit minimum
                                          • RAM: 512MB of free RAM

                                          Firewall Protocol

                                          • HTTP on port 80 or HTTPS on port 443
                                          • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                          • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                          Work-At-Home Attendees

                                          • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                          For A Seamless Experience

                                          When using a mobile device, FREE Mobile Apps are available:

                                          - For viewing Webinars:

                                          - For viewing Virtual Events

                                          Attendee Guide

                                          • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                          Virtual Event and Webinar Support:

                                          Continuing Education (CME/CE) Support

                                          Loading Comments...